Raquel Martinez

Summary

Publications

  1. ncbi Pulmonary nocardiosis: risk factors and outcomes
    Raquel Martínez Tomás
    Pneumology Service, Hospital Universitario La Fe, Valencia, and Universidad Autonoma de Barcelona, Barcelona, Spain
    Respirology 12:394-400. 2007
  2. ncbi Pulmonary nocardiosis: risk factors, clinical features, diagnosis and prognosis
    Raquel Martinez
    Service of Pneumology, University Hospital La Fe, Valencia, Spain
    Curr Opin Pulm Med 14:219-27. 2008
  3. ncbi Factors associated with inflammatory cytokine patterns in community-acquired pneumonia
    R Martinez
    Servicio de Neumologia, Hospital Universitario La Fe, Valencia, Spain
    Eur Respir J 37:393-9. 2011
  4. ncbi Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia
    Paula Ramirez
    Unidad de Cuidados Intensivos and Servicio de Neumologia, Hospital Universitario La Fe, Valencia, Spain
    Crit Care Med 39:2211-7. 2011
  5. ncbi Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in patients with acute respiratory distress syndrome and abdominal diseases: a preliminary observational study
    Paula Ramirez
    Department of Intensive Care Medicine, Hospital Universitario La Fe, Avda, Campanar 21, 46009 Valencia, Spain
    Crit Care 15:R50. 2011
  6. ncbi Impact of guidelines on outcome: the evidence
    Raquel Martinez
    Servicio de Neumologia, Hospital Universitario La Fe, Valencia, Valencia, Spain
    Semin Respir Crit Care Med 30:172-8. 2009

Collaborators

Detail Information

Publications6

  1. ncbi Pulmonary nocardiosis: risk factors and outcomes
    Raquel Martínez Tomás
    Pneumology Service, Hospital Universitario La Fe, Valencia, and Universidad Autonoma de Barcelona, Barcelona, Spain
    Respirology 12:394-400. 2007
    ..which can behave either as opportunistic or primary pathogens. The present study identifies the risk factors for PN, clinical symptoms and radiographic features and the factors that affect its prognosis...
  2. ncbi Pulmonary nocardiosis: risk factors, clinical features, diagnosis and prognosis
    Raquel Martinez
    Service of Pneumology, University Hospital La Fe, Valencia, Spain
    Curr Opin Pulm Med 14:219-27. 2008
    ..This review analyzes the current situation, in order to better understand this infection and enhance awareness and clinical suspicion that would lead to further specific microbiological studies and treatment...
  3. ncbi Factors associated with inflammatory cytokine patterns in community-acquired pneumonia
    R Martinez
    Servicio de Neumologia, Hospital Universitario La Fe, Valencia, Spain
    Eur Respir J 37:393-9. 2011
    ....
  4. ncbi Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia
    Paula Ramirez
    Unidad de Cuidados Intensivos and Servicio de Neumologia, Hospital Universitario La Fe, Valencia, Spain
    Crit Care Med 39:2211-7. 2011
    ..We assessed the relationship between inflammatory response, prediction for intensive care unit admission, delayed intensive care unit admission, and outcome in patients with community-acquired pneumonia...
  5. ncbi Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in patients with acute respiratory distress syndrome and abdominal diseases: a preliminary observational study
    Paula Ramirez
    Department of Intensive Care Medicine, Hospital Universitario La Fe, Avda, Campanar 21, 46009 Valencia, Spain
    Crit Care 15:R50. 2011
    ..For this purpose, we measured soluble triggering receptor expression on myeloid cells-1 (sTREM-1) in alveolar and peritoneal fluid...
  6. ncbi Impact of guidelines on outcome: the evidence
    Raquel Martinez
    Servicio de Neumologia, Hospital Universitario La Fe, Valencia, Valencia, Spain
    Semin Respir Crit Care Med 30:172-8. 2009
    ..Finally, the choice of antibiotics that adhere to the guidelines is cost-effective in CAP requiring hospitalization, which is responsible for 80% of the total cost of this disease...